Dec 1
|
Pfizer drops plan for twice-daily obesity pill due to side effects
|
Dec 1
|
Will Novo Nordisk Be a Trillion-Dollar Stock by 2030?
|
Dec 1
|
UPDATE 3-EU watchdog seeks more data from GLP-1 drugmakers on suicidal thoughts
|
Dec 1
|
UPDATE 4-Pfizer drops twice-daily version of obesity pill over side effects
|
Nov 30
|
FDA Accepts Karuna's (KRTX) NDA Filing for Schizophrenia Drug
|
Nov 30
|
Is it a Good Idea to Invest in Harpoon (HARP) Stock Now?
|
Nov 30
|
Weight loss drugs likely to boost apparel stocks: Survey
|
Nov 30
|
Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies
|
Nov 30
|
UPDATE 2-Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies
|
Nov 29
|
Emergent (EBS) Gets $75M BARDA Contract for Anthrax Vaccine
|
Nov 29
|
Is Alpine Immune Sciences (ALPN) Outperforming Other Medical Stocks This Year?
|
Nov 29
|
Merck's (MRK) Pneumococcal Jab Shows Upbeat Responses in Study
|
Nov 29
|
Ozempic Receives Some Very Bad News: Is It Time to Sell Novo Nordisk Stock?
|
Nov 29
|
15 Most Socialist States In The US
|
Nov 28
|
UPDATE 1-Suspected fake Ozempic causes hypoglycemia in 11 in Lebanon
|
Nov 28
|
Lilly's Weight-Loss Drug Wallops Novo's In Head-To-Head Study; Novo Stock Dives
|
Sep 10
|
Investors May Not Have Seen the Best From Eli Lilly Stock Yet. Here's Why.
|
Sep 9
|
10 Biotech Stocks with Biggest Upside
|
Sep 9
|
3 Top Healthcare Stocks to Buy for September
|
Sep 8
|
Novo Nordisk (NVO) Gains But Lags Market: What You Should Know
|